Glycerin

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, imprinted with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for application to the genital area for a duration of 5 minutes.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product is intended for external use only. Healthcare professionals should ensure that the application site is clean and dry prior to administration. The recommended dosage and frequency of application will depend on the specific condition being treated.

Patients should apply the product to the affected area as directed, typically using a thin layer. It is important to avoid contact with eyes, mucous membranes, and open wounds. The frequency of application may vary; therefore, healthcare professionals should provide specific instructions based on individual patient needs and the severity of the condition.

Instruct patients to wash their hands thoroughly after applying the product, unless the hands are the treated area. If a dose is missed, patients should apply the product as soon as they remember, unless it is close to the time of the next scheduled application. In such cases, they should skip the missed dose and resume the regular dosing schedule.

Healthcare professionals should monitor patients for any adverse reactions and adjust the treatment regimen as necessary.

Contraindications

Use is contraindicated in patients who experience skin irritation; in such cases, the product should be washed off with water and discontinued. Additionally, if symptoms do not improve, medical attention should be sought immediately. The product should also be stopped if any wound breaks occur.

Warnings and Precautions

Ingestion of the product by mouth is strictly prohibited. Healthcare professionals should advise patients to avoid any contact with the eyes or ears, as this may lead to adverse effects. Additionally, the product must not come into contact with open wounds to prevent potential complications.

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately. Should skin irritation occur, the affected area should be washed thoroughly with water, and use of the product should be discontinued. If symptoms persist or do not improve, prompt medical attention is necessary to ensure patient safety.

It is essential to monitor for any signs of wound breaks, as this may indicate a need for further evaluation and intervention.

Side Effects

In clinical use, patients should be advised against ingesting the product orally, as this may lead to serious adverse reactions. Additionally, contact with the eyes or ears is contraindicated, as such exposure could result in significant irritation or injury. The product should not be applied to open wounds, as this may exacerbate the condition or lead to further complications.

In the context of over-the-counter (OTC) use, patients are instructed to discontinue use if any wound breaks occur, as this may indicate an adverse reaction or an inappropriate application of the product. It is essential for patients to adhere to these warnings to minimize the risk of serious adverse effects.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Female Sensual Cream. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

The product is intended for external use only, and no specific pediatric use information is provided in the prescribing information. There are no age restrictions or dosing differences noted for pediatric patients. Additionally, the text does not indicate any safety concerns or special precautions for children.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

Nursing mothers should exercise caution when using this product due to the potential for excretion in breast milk. It is recommended that lactating mothers consult a healthcare provider before using this product while breastfeeding to assess any potential risks to the infant.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of overdosage, it is imperative to prohibit ingestion by mouth. Healthcare professionals should be vigilant in monitoring for potential symptoms associated with overdosage, which may vary depending on the specific substance involved.

Management of overdosage should include immediate assessment of the patient's condition and the implementation of appropriate supportive measures. It is essential to provide symptomatic treatment as necessary and to consider contacting a poison control center for further guidance.

In cases where the substance is known to cause severe adverse effects, additional interventions may be required. Continuous monitoring of vital signs and supportive care should be prioritized to ensure patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Skin irritation has been reported in postmarketing experience, with recommendations to wash the affected area with water and discontinue use of the product. In cases where symptoms do not improve, it is advised to seek medical attention promptly. Additionally, if the product is ingested, it is crucial to obtain medical help or contact a Poison Control Center immediately.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients about the potential for skin irritation; they should wash the affected area with water and discontinue use if irritation occurs.

Patients should be counseled to monitor their symptoms closely and to seek medical attention immediately if symptoms do not improve. Additionally, healthcare providers should instruct patients to allow a minimum of 5 minutes for the product to take effect before assessing its efficacy.

Storage and Handling

The product is available in various package configurations, with specific NDC numbers assigned for identification. Storage and handling instructions are not explicitly provided; therefore, standard practices for pharmaceutical products should be followed. It is advisable to store the product in a controlled environment, ensuring that it is kept at appropriate temperature ranges to maintain its integrity. Containers should be secure and suitable for the product type to prevent contamination or degradation. Special handling requirements are not specified, but general precautions should be taken to ensure the product's safety and efficacy during storage and transport.

Additional Clinical Information

The product is administered via the vaginal route, requiring application to the genitals for a duration of 5 minutes. Clinicians should counsel patients on the importance of prohibiting ingestion by mouth and avoiding contact with eyes, ears, or wounds. It is intended for external use only. Patients should be advised to wash the area with water and discontinue use if skin irritation occurs. If symptoms do not improve, patients are encouraged to seek medical attention promptly. In the event of accidental ingestion, immediate medical help or contact with a Poison Control Center is essential.

Drug Information (PDF)

This file contains official product information for Female Sensual Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)